NYSE: DVA - DaVita

Yield per half year: +22.36%
Sector: Healthcare

Company Analysis DaVita

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (58.5%) is higher than the sector average (-2.16%).
  • Current debt level 49.87% is below 100% and has decreased over 5 years from 64.59%.
  • The company's current efficiency (ROE=65.48%) is higher than the sector average (ROE=-80.86%)

Disadvantages

  • Price (153.4 $) is higher than fair price (91.77 $)
  • Dividends (0%) are below the sector average (1.31%).

Similar companies

PFIZER

PerkinElmer

Humana

AbbVie

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

DaVita Healthcare Index
7 days 2.4% 2.4% 1.7%
90 days 8.5% -6.3% 4.6%
1 year 58.5% -2.2% 24.9%

DVA vs Sector: DaVita has outperformed the "Healthcare" sector by 60.66% over the past year.

DVA vs Market: DaVita has outperformed the market by 33.62% over the past year.

Stable price: DVA is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: DVA with weekly volatility of 1.13% over the past year.

3. Summary of the report

3.1. General

P/E: 14.06
P/S: 0.8008

3.2. Revenue

EPS 7.42
ROE 65.48%
ROA 3.92%
ROIC 8.72%
Ebitda margin 19.33%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (153.4 $) is higher than the fair price (91.77 $).

Price is higher than fair: The current price (153.4 $) is 40.2% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (14.06) is lower than that of the sector as a whole (57.88).

P/E vs Market: The company's P/E (14.06) is lower than that of the market as a whole (47.66).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (3.54) is lower than that of the sector as a whole (9.4).

P/BV vs Market: The company's P/BV (3.54) is lower than that of the market as a whole (22.59).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.8008) is lower than that of the sector as a whole (4.07).

P/S vs Market: The company's P/S indicator (0.8008) is lower than that of the market as a whole (15.21).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (8.68) is lower than that of the sector as a whole (17.62).

EV/Ebitda vs Market: The company's EV/Ebitda (8.68) is lower than that of the market as a whole (24.14).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -2.12% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-2.12%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-66.62%).

5.4. ROE

ROE vs Sector: The company's ROE (65.48%) is higher than that of the sector as a whole (-80.86%).

ROE vs Market: The company's ROE (65.48%) is higher than that of the market as a whole (18.07%).

5.5. ROA

ROA vs Sector: The company's ROA (3.92%) is lower than that of the sector as a whole (6.71%).

ROA vs Market: The company's ROA (3.92%) is lower than that of the market as a whole (6.49%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (8.72%) is lower than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (8.72%) is lower than that of the market as a whole (9.31%).

6. Finance

6.1. Assets and debt

Debt level: (49.87%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 64.59% to 49.87%.

Excess of debt: The debt is not covered by net income, percentage 1270.51%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '1.31%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (34.88%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
27.11.2024 Waters Kathleen Alyce
Chief Legal & Pub. Affairs Off
Purchase 108.93 879 937 8 078
27.11.2024 Michael Staffieri
Officer
Purchase 167.09 1 320 340 7 902
13.08.2024 Kathleen Waters
Officer
Purchase 146.2 1 148 690 7 857
12.05.2023 YALE PHYLLIS R
Director
Sale 95.26 209 191 2 196
12.05.2023 YALE PHYLLIS R
Director
Purchase 66.29 474 968 7 165

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum DaVita

9.3. Comments